| Financial Year |
March 31 2023 |
| Monetary Funds |
770,928,667.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
12,498,391.50 |
| Accounts Receivable |
2,631,012,458.27 |
| Advances to Suppliers |
26,899,245.62 |
| Other Receivables |
507,416,775.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
606,373,577.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,911,720.29 |
| Total Current Assets |
4,662,549,490.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
507,856,142.10 |
| Investment Properties |
6,833,757.06 |
| Fixed Assetes |
435,965,487.88 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
781,841,737.41 |
| R&D expenses |
285,445,264.05 |
| Goodwill |
4,587,904,498.90 |
| Long-Term Deferred and Prepaid Expenses |
40,246,357.05 |
| Deferred Income Tax Assets |
129,283,272.17 |
| Other Non-Current Assets |
15,681,902.38 |
| Sub-Total of Non-Current Assets |
7,224,465,634.63 |
| Total Assets |
11,887,015,125.44 |
| Short-Term Loans |
127,153,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
67,659,769.00 |
| Accounts Payable |
926,662,621.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
264,636,319.99 |
| Taxes Payable |
62,043,785.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
296,860,355.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,427,780.26 |
| Other Current Liabilities |
5,804,702.77 |
| Sub-Total of Current Liabilities |
1,949,445,342.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,381,306.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
205,374,331.78 |
| Total Liabilities |
2,154,819,674.48 |
| Paid-In Capital(Or Share Stock) |
1,184,832,393.00 |
| Capital Surplus |
6,470,625,282.13 |
| Surplus Reserve |
141,979,059.38 |
| LESS:Treasury Stock |
769,072,375.27 |
| Undistributed Profits |
2,710,287,925.40 |
| Minority Stockholder's Interest |
2,093,166.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,730,102,284.64 |
| Owner's Equity（Stockholder's Equity） |
9,732,195,450.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,887,015,125.44 |
